MC
BSX icon

Moors & Cabot’s Boston Scientific BSX Stock Holding History

Moors & Cabot’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-400
Closed -$1.84K – 884
2024
Q4 		$1.84K Buy
+400
New +$35.2K ﹤0.01% 882

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Moors & Cabot's BSX Position: Q2 2026 in Review

Moors & Cabot increased its Boston Scientific (BSX) stake by 7% in Q2 2026, buying an estimated $107K and bringing the position to 30,010 shares worth $1.28M. The position accounts for 0.05% of the portfolio, ranked #330.

Moors & Cabot first reported a position in BSX in Q1 2014 and has held it in 50 quarters since. The position peaked at $2.82M in Q2 2025. 1,484 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Moors & Cabot held 30,010 shares of Boston Scientific worth $1.28M as of Q2 2026.
  • Moors & Cabot bought 1,971 Boston Scientific shares in Q2 2026, an estimated $107K.
  • Boston Scientific made up 0.05% of Moors & Cabot's portfolio in Q2 2026, its #330 holding.
  • Moors & Cabot first reported a position in Boston Scientific in Q1 2014 and has held it in 50 quarters since.
  • Moors & Cabot's Boston Scientific position peaked at $2.82M in Q2 2025.
  • 1,484 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.